These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23495532)

  • 1. Genetic variant links hepatitis C virus clearance and treatment response.
    McBride D
    ONS Connect; 2013 Mar; 28(1):50. PubMed ID: 23495532
    [No Abstract]   [Full Text] [Related]  

  • 2. Introduction to the genetics and biology of interleukin-28B.
    Urban T; Charlton MR; Goldstein DB
    Hepatology; 2012 Jul; 56(1):361-6. PubMed ID: 22511448
    [No Abstract]   [Full Text] [Related]  

  • 3. The Effects of IL-28B and ITPA polymorphisms on treatment of hepatitis C virus genotype 6.
    Seto WK; Tanaka Y; Liu K; Lai CL; Yuen MF
    Am J Gastroenterol; 2011 May; 106(5):1007-8. PubMed ID: 21540909
    [No Abstract]   [Full Text] [Related]  

  • 4. A single nucleotide polymorphism in IL28B affects viral evolution of hepatitis C quasispecies after pegylated interferon and ribavirin therapy.
    Yuan H; Adams-Huet B; Petersen T; Attar N; Lee WM; Jain MK
    J Med Virol; 2012 Dec; 84(12):1913-9. PubMed ID: 23080496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of interleukin-28B testing in patients with genotype 1.
    Lai M; Afdhal NH
    Hepatology; 2012 Jul; 56(1):367-72. PubMed ID: 22511388
    [No Abstract]   [Full Text] [Related]  

  • 6. Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C.
    Benito JM; García-Samaniego J; García M; Madejón A; Martín-Carbonero L; Cabello A; Álvarez B; Górgolas M; Rallón N
    J Interferon Cytokine Res; 2017 Jun; 37(6):278-286. PubMed ID: 28440692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of IL-28B SNPs on control of hepatitis C virus infection: a genome-wide association study.
    Imazeki F; Yokosuka O; Omata M
    Expert Rev Anti Infect Ther; 2010 May; 8(5):497-9. PubMed ID: 20455677
    [No Abstract]   [Full Text] [Related]  

  • 8. Genomics: Hepatitis C virus gets personal.
    Iadonato SP; Katze MG
    Nature; 2009 Sep; 461(7262):357-8. PubMed ID: 19759611
    [No Abstract]   [Full Text] [Related]  

  • 9. IFNL4 ss469415590 variant shows similar performance to rs12979860 as predictor of response to treatment against Hepatitis C Virus genotype 1 or 4 in Caucasians.
    Real LM; Neukam K; Herrero R; Guardiola JM; Reiberger T; Rivero-Juarez A; Salazar J; Mandorfer M; Merino D; Soriano V; Rivero A; Macías J; Pineda JA; Caruz A
    PLoS One; 2014; 9(4):e95515. PubMed ID: 24748394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of IL-28B, TBX21 gene polymorphisms and predictors of virological response for chronic hepatitis C.
    Zhu DY; Deng XZ; Zhu YM; Li GT; Zhang GQ; Wang LJ; Zhang JH; Xiao W; Zhou ZX; Ding WL
    Arch Virol; 2018 May; 163(5):1253-1262. PubMed ID: 29399747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFNL4 ss469415590 polymorphism contributes to treatment decisions in patients with chronic hepatitis C virus genotype 1b, but not 2a, infection.
    Wu R; Chi X; Wang X; Sun H; Lv J; Gao X; Yu G; Kong F; Xu H; Hua R; Jiang J; Sun B; Zhong J; Pan Y; Niu J
    Infect Genet Evol; 2016 Apr; 39():132-140. PubMed ID: 26820907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral evolution explains the associations among hepatitis C virus genotype, clinical outcomes, and human genetic variation.
    Rose R; Markov PV; Lam TT; Pybus OG
    Infect Genet Evol; 2013 Dec; 20():418-21. PubMed ID: 24140473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of IL28B SNPs on therapeutic outcome and liver histology differs between hepatitis C virus genotypes.
    Lagging M
    Pharmacogenomics; 2012 Jun; 13(8):847-9. PubMed ID: 22676186
    [No Abstract]   [Full Text] [Related]  

  • 14. Association between CXCL10 and DPP4 Gene Polymorphisms and a Complementary Role for Unfavorable IL28B Genotype in Prediction of Treatment Response in Thai Patients with Chronic Hepatitis C Virus Infection.
    Thanapirom K; Suksawatamnuay S; Sukeepaisarnjaroen W; Tangkijvanich P; Treeprasertsuk S; Thaimai P; Wasitthankasem R; Poovorawan Y; Komolmit P
    PLoS One; 2015; 10(9):e0137365. PubMed ID: 26339796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between IL28B polymorphisms and first-phase viral load decrease in chronic hepatitis C virus-infected patients treated with peginterferon alfa-2b/ribavirin.
    Arends JE; Fransen JH; Hoepelman AI; van Baarle D
    Int J Antimicrob Agents; 2011 Dec; 38(6):538-9. PubMed ID: 21974859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of interleukin 28B-related gene polymorphisms in chronic hepatitis C and the response to antiviral therapy in Koreans.
    Jung YK; Kim JH; Ahn SM; Yang JW; Park SJ; Kim JW; Yeon JE; Kwon OS; Kim YS; Choi DJ; Kim JH; Byun KS
    J Clin Gastroenterol; 2013 Aug; 47(7):644-50. PubMed ID: 23442843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding triphasic HCV decline during treatment in the era of IL28B polymorphisms and direct acting antiviral agents via mathematical modeling.
    Dahari H; Cotler SJ; Layden TJ; Perelson AS
    J Hepatol; 2013 Apr; 58(4):840-2. PubMed ID: 23246507
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply to: "Understanding triphasic HCV decline during treatment in the era of IL28B polymorphisms and direct acting antiviral agents via mathematical modeling".
    Howell CD; Jin R; Dowling TC
    J Hepatol; 2013 Apr; 58(4):842-3. PubMed ID: 23246702
    [No Abstract]   [Full Text] [Related]  

  • 19. IL28B: A new wager in the skyline of hepatitis C virus infection.
    Mangia A
    Dig Liver Dis; 2011 Mar; 43(3):177-9. PubMed ID: 21237729
    [No Abstract]   [Full Text] [Related]  

  • 20. IL28B genetic variants and gender are associated with spontaneous clearance of hepatitis C virus infection.
    Rao HY; Sun DG; Jiang D; Yang RF; Guo F; Wang JH; Liu F; Zhang HY; Zhang HH; Du SC; Jin Q; Qin H; Lok AS; Wei L
    J Viral Hepat; 2012 Mar; 19(3):173-81. PubMed ID: 22329371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.